HighTide Therapeutics Sets 31 Aug 2026 Board Meeting to Approve Interim Results

Bulletin Express

08/14

HighTide Therapeutics, Inc. has scheduled a board meeting for Monday, 31 August 2026. According to the company’s announcement, the agenda includes consideration and approval of the interim financial results for the six months ended 30 June 2026 and their subsequent publication, along with other corporate matters.

The notice, issued by Executive Director and Chief Executive Officer Dr. Liu Liping on 14 August 2026, confirms the current composition of the Board: two executive directors (Dr. Liu Liping and Ms. Yu Meng), three non-executive directors (Dr. Zhu Xun, Mr. Ma Lixiong and Mr. Jiang Feng), and three independent non-executive directors (Dr. Li Jin, Mr. Hung Tak Wai and Mr. Chen Mingyu).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1159748596"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159748596\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1159748596?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159748596","market":"hk","top_or_hot":-1,"title":"HighTide Therapeutics Sets 31 Aug 2026 Board Meeting to Approve Interim Results","media":"Bulletin Express","content":"<p>HighTide Therapeutics, Inc. has scheduled a board meeting for Monday, 31 August 2026. According to the company’s announcement, the agenda includes consideration and approval of the interim financial results for the six months ended 30 June 2026 and their subsequent publication, along with other corporate matters.</p>\n<p>The notice, issued by Executive Director and Chief Executive Officer Dr. Liu Liping on 14 August 2026, confirms the current composition of the Board: two executive directors (Dr. Liu Liping and Ms. Yu Meng), three non-executive directors (Dr. Zhu Xun, Mr. Ma Lixiong and Mr. Jiang Feng), and three independent non-executive directors (Dr. Li Jin, Mr. Hung Tak Wai and Mr. Chen Mingyu).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HighTide Therapeutics Sets 31 Aug 2026 Board Meeting to Approve Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHighTide Therapeutics Sets 31 Aug 2026 Board Meeting to Approve Interim Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-14 16:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>HighTide Therapeutics, Inc. has scheduled a board meeting for Monday, 31 August 2026. According to the company’s announcement, the agenda includes consideration and approval of the interim financial results for the six months ended 30 June 2026 and their subsequent publication, along with other corporate matters.</p>\n<p>The notice, issued by Executive Director and Chief Executive Officer Dr. Liu Liping on 14 August 2026, confirms the current composition of the Board: two executive directors (Dr. Liu Liping and Ms. Yu Meng), three non-executive directors (Dr. Zhu Xun, Mr. Ma Lixiong and Mr. Jiang Feng), and three independent non-executive directors (Dr. Li Jin, Mr. Hung Tak Wai and Mr. Chen Mingyu).</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02511","symbol_name":"君聖泰醫藥-B","start_time":0,"source_url":"","article_id":"1159748596","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159748596","pubTimestamp":1786697131,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"HighTide Therapeutics, Inc. has scheduled a board meeting for Monday, 31 August 2026. According to the company’s announcement, the agenda includes consideration and approval of the interim financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02511":"君圣泰医药-B"},"translate_title":"HighTide Therapeutics 定于 2026 年 8 月 31 日召开董事会会议批准中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02511":1},"content_text":"HighTide Therapeutics, Inc. has scheduled a board meeting for Monday, 31 August 2026. According to the company’s announcement, the agenda includes consideration and approval of the interim financial results for the six months ended 30 June 2026 and their subsequent publication, along with other corporate matters.\nThe notice, issued by Executive Director and Chief Executive Officer Dr. Liu Liping on 14 August 2026, confirms the current composition of the Board: two executive directors (Dr. Liu Liping and Ms. Yu Meng), three non-executive directors (Dr. Zhu Xun, Mr. Ma Lixiong and Mr. Jiang Feng), and three independent non-executive directors (Dr. Li Jin, Mr. Hung Tak Wai and Mr. Chen Mingyu).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}